Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201102043 Principal Investigator: Vij, Ravi
Title: A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Refractory/Relapsed Multiple Myeloma
Phase: I/II Disease Site: Multiple Myeloma
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to learn about the safety of two anticancer drugs called carfilzomib and pegylated liposomal doxorubicin (PLD) when given together, to see what effects these drugs have on the body and on your disease, and to determine the highest safest dose of carfilzomib that can be given in combination with PLD.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)